How to Choose an SEO Company for Healthcare Professionals

How a vendor should read HIPAA marketing rules

Before discussing rankings, inquire how a candidate agency defines marketing under HIPAA. The Privacy Rule mandates written patient authorization for using or disclosing protected health information for marketing, with limited exceptions ⁵. Communications describing a covered entity’s own health-related products or services are generally exempt, allowing treatment centers to produce service pages, program descriptions, and clinician bios without triggering authorization requirements ⁶.

The distinction becomes less clear with remarketing audiences built from site visitors, condition-segmented email nurture sequences, or partner referral campaigns involving third-party services. A vendor unable to differentiate between promoting the center’s own services and promoting a third party’s offering for remuneration is likely to create campaigns requiring authorization that the practice has not obtained ^{5, 6}.

To assess this competency, ask two questions:

1. “Which of our planned tactics involve PHI, and where does the authorization requirement apply?”
2. “How do you configure email lists, form submissions, and CRM handoffs to prevent a patient inquiry about detox from becoming data sold, syndicated, or repurposed into a lookalike audience?”

An agency providing generic assurances about being “HIPAA-aware” describes a posture, not a workflow. One that references 45 CFR 164.501 and 164.508(a)(3) and can name exceptions demonstrates actual understanding of the regulations.

The OCR tracking bulletin and what it exposes in a proposal

The most rigorous technical assessment in a proposal review concerns the tracking stack. The HHS Office for Civil Rights has clarified that regulated entities cannot use tracking technologies in ways that impermissibly disclose PHI to tracking vendors, and authenticated pages with tracking scripts must be configured to prevent HIPAA violations ¹⁶. The 2022 HIPAA compliance report to Congress specifically highlighted concerns about covered entities using tools like Google Analytics and Meta Pixel to collect website user information, noting that these implementations can lead to impermissible PHI disclosures and investigations ¹⁷.

This guidance has led to varying risk approaches. Some HIPAA-regulated institutions have opted to remove Google Analytics and similar third-party tracking tools entirely from any web content that could be regulated by HIPAA ¹⁸. Others argue that unauthenticated marketing pages without identifiers can be measured with standard analytics if filters, IP anonymization, and consent flows are properly configured. Both interpretations exist because OCR’s guidance allows for risk analysis rather than a single technical mandate ¹⁶.

A marketing manager should ask the vendor to explicitly state its position on this spectrum:

• Which pages will use GA4?
• Which will use Meta Pixel or LinkedIn Insight?
• Is call tracking routed through a HIPAA-compliant provider with a Business Associate Agreement (BAA), or a consumer platform that logs numbers to a third party?
• What happens on the thank-you page after a form submission—does the URL contain condition information that then transmits to an ad network?

FTC substantiation and the testimonial trap in addiction treatment

Behavioral health faces greater FTC scrutiny than most healthcare verticals due to its reliance on outcome language—recovery, sobriety, relapse prevention—which is challenging to substantiate without published clinical data specific to the facility. The FTC requires adequate substantiation for all objective product claims, and health-related claims demand a higher evidentiary standard ³. The 2022 Health Products Compliance Guidance update reiterated that health service marketers must meet contemporary standards for truthful, substantiated claims and clarified endorsement expectations ²¹.

Testimonials are a common area of non-compliance. FTC guidance broadly defines endorsements as any advertising message likely to reflect opinions or experiences other than the advertiser’s own, requiring advertisers to possess adequate substantiation—including competent and reliable scientific evidence when appropriate—for claims conveyed through these endorsements ²⁰. Unrepresentative testimonials can be misleading if not accompanied by information about what consumers can generally expect from the service ²². For example, a patient success story stating, “I’ve been sober for three years thanks to this program,” implies a general outcome that the facility must be able to support with data if presented as typical ^{19, 22}.

A vendor evaluation should include reviewing the candidate’s existing client sites. Look for phrases like “success rate,” “lifelong recovery,” or before-and-after language. Observe how testimonials are framed and whether disclaimers about typical results are present. If the vendor’s portfolio contains unsubstantiated outcome claims, similar patterns will likely appear in the proposed content plan, and the liability will fall on the treatment center, not the agency.

Condition-level depth over keyword breadth

A common flaw in behavioral health SEO proposals is a lengthy keyword list paired with content briefs that treat each condition as a 900-word service page. This approach prioritizes surface area over how patients and families actually search. A cross-sectional study of 381 primary care patients with chronic diseases found that 54.7% used the internet to search for health information ¹⁴. While this study focused on primary care, the pattern holds: individuals managing a persistent condition—or a family member’s—repeatedly use search, ask increasingly specific questions, and favor sites that provide detailed answers.

For a treatment center, this means condition depth is more valuable than keyword breadth. Alcohol use disorder requires a cluster of content covering withdrawal timelines, medication-assisted treatment options, co-occurring depression or anxiety, family involvement, aftercare planning, and the first thirty days post-discharge. Fentanyl, benzodiazepines, and stimulants each demand similar depth. A vendor proposing a flat list of service pages without a topic architecture that addresses follow-up questions will achieve shallow rankings on high-volume head terms but lack visibility for the long-tail queries that truly convert.

Ask candidates to showcase topic clusters they have built for comparable clients and the organic call volume these clusters generated, rather than just ranking screenshots.

Clinical accuracy, governance, and the AMA-informed content standard

Depth without accuracy creates liability. Content that inaccurately describes withdrawal symptoms, misrepresents buprenorphine’s mechanism, or overstates evidence for a therapy will be flagged by referring clinicians and, eventually, by search engines that increasingly prioritize expertise in health topics. A competent vendor integrates clinical review as a standard workflow step, not a final courtesy check.

During a proposal review, emphasize three governance anchors:

• AMA principles for medical websites advocate for clear separation of editorial and advertising content, visible authorship, and privacy protections for site visitors ¹⁰.
• AMA guidance on electronic communication with patients extends confidentiality and security expectations to contact forms, chat widgets, and any tool capturing inbound inquiries ⁸.
• Its social media policy adds a professionalism layer, requiring content amplified across channels to respect patient confidentiality and avoid unsubstantiated claims ⁹.

Together, these define a defensible content operation: bylined pages with clinician review, contact surfaces that do not treat inquiries as marketing data, and social amplification adhering to the same accuracy standards as the website.

Research highlights the operational stakes. Patients generally view online information as complementary to clinical judgment, but poorly written content can induce anxiety, misinterpretation, and self-diagnostic behaviors that harm the clinical relationship ^{12, 13}. Conversely, content that clarifies when to seek professional care, sets realistic treatment expectations, and cites evidence appropriately is beneficial ².

Ask the vendor to identify its clinical reviewer, provide evidence of review sign-off for existing content, and describe how updates are triggered by guideline changes. If these answers are not readily available, the content plan is unlikely to meet medical director approval.

What to demand in a scope of work

The scope of work (SOW) document should explicitly commit the vendor to admissions calls as the key performance indicator (KPI), rather than allowing for reporting on rankings and sessions. A robust SOW will state the outcome metric in the first paragraph: qualified admissions calls attributed to organic search. This should be defined as inbound calls of a minimum duration from a non-branded organic session or a Google Business Profile interaction, deduplicated against paid and direct channels.

The document should then detail the deliverables the vendor will create and maintain:

• condition-level content clusters with named clinical reviewers and a review sign-off log
• Google Business Profile management for each facility with a documented HIPAA-compliant review response workflow (e.g., no confirmation of treatment for specific individuals in public replies ^{5, 6})
• schema markup for LocalBusiness and MedicalOrganization types
• a citation and NAP consistency audit with a remediation schedule

The measurement section of most proposals tends to be weak. Demand a call tracking implementation routed through a provider operating under a signed Business Associate Agreement. Also, require a monthly attribution report that reconciles organic-sourced calls with the admissions team’s disposition data, and a quarterly review linking content investment to call volume by cluster. Without this commitment, reporting will likely revert to sessions and keyword rankings, leaving the marketing manager unable to justify spend to clinical leadership with outcome data.

Attribution without PHI leakage

The attribution model must address two simultaneous requirements: identifying which organic content generated a call, and ensuring this measurement occurs without transmitting protected health information to third-party ad or analytics vendors. OCR has stated that regulated entities are prohibited from using tracking technologies in a way that results in impermissible PHI disclosures, including configurations where a page URL, form field, or event parameter reveals a user’s condition or treatment interest to a downstream platform ¹⁶.

An effective stack keeps identifiable data within systems covered by Business Associate Agreements. Call tracking should operate through a HIPAA-compliant provider under a signed BAA, not a consumer platform that logs numbers to an ad network. Form submissions on program pages should route to a CRM under a BAA, and thank-you page URLs must not carry condition parameters that would transmit to Meta or Google via a fired pixel. The FTC’s updated Health Breach Notification Rule reinforces these stakes, explicitly including products and services offered through websites and online services as PHR-related entities, thereby expanding breach notification obligations to a wider range of marketing and analytics tools ⁴. Telehealth landing pages integrating scheduling or intake tools require the same BAA scrutiny as the clinical platform itself ⁷.